Theresa Comiskey Olsen

Theresa Comiskey Olsen is currently Chairman at Farma Investment AS since 2020.
Other current roles include Director at Jotunfjell AS, Aptahem AB (since 2020), Ff Bygg Og Vedlikehold AS, Melius Pharma AB, and Gabather AB (since 2023).
Ms. Olsen is also a Partner at Nova Law Firm and Owner of Comiskey Olsen.
Former positions include Chairman at Mylifeproducts AS, Director at Aqua Bio Technology ASA (2011-2012), PCI Biotech Holding ASA, AspenTech Norway AS, Medsafe ASA, NattoPharma ASA, Bio Medisinsk Innovasjon AS, Serodus ASA, Calpro AS, Calpro Diagnostics, Inc., Nordic Nanovector ASA (Independent Director), Cyxone AB, Biovotec AS (Norway), and Managing Director at Magnus Innovasjon AS.
Ms. Olsen was Secretary & General Counsel at Nycomed ASA from 1990 to 2007.
Other former roles include Partner at Langseth Advokatfirma DA, Partner & Owner at Advokatfirmaet Nova Da, and Attorney at Albaran Advokat Da.
Education includes undergraduate studies at the University of Pennsylvania and graduate degrees from the University of Detroit Mercy and the University of Detroit Mercy School of Law.